Visualizing hepatitis C virus infection in humanized mice

Journal of Immunological Methods

Volumn 410, Issue , 2014, Pages 50-59

  von Schaewen, Markus ^a   Ding, Qiang ^a   Ploss, Alexander ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

Animal model; Hepatitis C virus; Humanized mice; Imaging; Viral hepatitis

Indexed keywords

CRE RECOMBINASE;

ANIMAL CELL CULTURE; ARTICLE; DISEASE CARRIER; HEPATITIS C; HOST; HUMAN; LIVER CELL CULTURE; LIVER DISEASE; MOUSE MODEL; NONHUMAN; PERSISTENT INFECTION; REPORTER GENE; STAINING; XENOTRANSPLANTATION; ANIMAL; ANIMAL MODEL; DISEASE MODEL; GENETICS; HEPATITIS C VIRUS; HUMANIZED MICE; IMAGING; LIVER; LIVER CELL; METABOLISM; MOUSE; PATHOLOGY; REVIEW; VIROLOGY; VIRUS HEPATITIS;

ANIMAL MODEL; HEPATITIS C VIRUS; HUMANIZED MICE; IMAGING; VIRAL HEPATITIS;

ANIMALS; DISEASE MODELS, ANIMAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; LIVER; MICE;

EID: 84908509736     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.03.006     Document Type: Article

References (118)

1. Agnello V., Abel G., Elfahal M., Knight G.B., Zhang Q.-X. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:12766-12771.
2. Amako Y., Tsukiyama-Kohara K., Katsume A., Hirata Y., Sekiguchi S., Tobita Y., Hayashi Y., Hishima T., Funata N., Yonekawa H., Kohara M. Pathogenesis of hepatitis C virus infection in Tupaia belangeri. J. Virol. 2010, 84:303-311.
3. Andrus L., Marukian S., Jones C.T., Catanese M.T., Sheahan T.P., Schoggins J.W., Barry W.T., Dustin L.B., Trehan K., Ploss A., Bhatia S.N., Rice C.M. Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology 2011, 54:1901-1912.
4. -/- mice. Nat. Biotechnol. 2007, 25:903-910.
5. Bartenschlager R., Penin F., Lohmann V., Andre P. Assembly of infectious hepatitis C virus particles. Trends Microbiol. 2011, 19:95-103.
6. Barth H., Schafer C., Adah M.I., Zhang F., Linhardt R.J., Toyoda H., Kinoshita-Toyoda A., Toida T., Van Kuppevelt T.H., Depla E., Von Weizsacker F., Blum H.E., Baumert T.F. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 2003, 278:41003-41012.
7. Billerbeck E., de Jong Y., Dorner M., de la Fuente C., Ploss A. Animal models for hepatitis C. Curr. Top. Microbiol. Immunol. 2013, 369:49-86.
8. Bissig K.D., Le T.T., Woods N.B., Verma I.M. Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20507-20511.
9. Bissig K.D., Wieland S.F., Tran P., Isogawa M., Le T.T., Chisari F.V., Verma I.M. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J. Clin. Invest. 2010, 120:924-930.
10. Brezillon N.M., DaSilva L., L'Hote D., Bernex F., Piquet J., Binart N., Morosan S., Kremsdorf D. Rescue of fertility in homozygous mice for the urokinase plasminogen activator transgene by the transplantation of mouse hepatocytes. Cell Transplant. 2008, 17:803-812.
11. Bukh J. A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 2004, 39:1469-1475.
12. Bukh J., Apgar C.L., Govindarajan S., Purcell R.H. Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J. Med. Virol. 2001, 65:694-697.
13. Burbelo P.D., Dubovi E.J., Simmonds P., Medina J.L., Henriquez J.A., Mishra N., Wagner J., Tokarz R., Cullen J.M., Iadarola M.J., Rice C.M., Lipkin W.I., Kapoor A. Serology Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host. J. Virol. 2012, 86:6171-6178.
14. Chang K.S., Cai Z., Zhang C., Sen G.C., Williams B.R., Luo G. Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J. Virol. 2006, 80:7364-7374.
15. Chen A.A., Thomas D.K., Ong L.L., Schwartz R.E., Golub T.R., Bhatia S.N. Humanized mice with ectopic artificial liver tissues. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11842-11847.
16. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244:359-362.
17. Deforges S., Evlashev A., Perret M., Sodoyer M., Pouzol S., Scoazec J.Y., Bonnaud B., Diaz O., Paranhos-Baccala G., Lotteau V., Andre P. Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo. J. Gen. Virol. 2004, 85:2515-2523.
18. Diao J., Pantua H., Ngu H., Komuves L., Diehl L., Schaefer G., Kapadia S.B. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry. J. Virol. 2012, 86:10935-10949.
19. Dorner M., Horwitz J.A., Robbins J.B., Barry W.T., Feng Q., Mu K., Jones C.T., Schoggins J.W., Catanese M.T., Burton D.R., Law M., Rice C.M., Ploss A. A genetically humanized mouse model for hepatitis C virus infection. Nature 2011, 474:208-211.
20. Dorner M., Horwitz J.A., Donovan B.M., Labitt R.N., Budell W.C., Friling T., Vogt A., Catanese M.T., Satoh T., Kawai T., Akira S., Law M., Rice C.M., Ploss A. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 2013, 501:237-241.
21. Ducoulombier D., Roque-Afonso A.M., Di Liberto G., Penin F., Kara R., Richard Y., Dussaix E., Feray C. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004, 39:817-825.
22. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wolk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007, 446:801-805.
23. Frentzen A., Huging K., Bitzegeio J., Friesland M., Haid S., Gentzsch J., Hoffmann M., Lindemann D., Zimmer G., Zielecki F., Weber F., Steinmann E., Pietschmann T. Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines. PLoS Pathog. 2011, 7:e1002029.
24. Frentzen A., Anggakusuma, Gurlevik E., Hueging K., Knocke S., Ginkel C., Brown R.J., Heim M., Dill M.T., Kroger A., Kalinke U., Kaderali L., Kuehnel F., Pietschmann T. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells. Hepatology 2014, 59:78-88.
25. Grakoui A., McCourt D.W., Wychowski C., Feinstone S.M., Rice C.M. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 1993, 67:2832-2843.
26. Griffin S.D., Beales L.P., Clarke D.S., Worsfold O., Evans S.D., Jaeger J., Harris M.P., Rowlands D.J. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett. 2003, 535:34-38.
27. Grompe M., al-Dhalimy M., Finegold M., Ou C.N., Burlingame T., Kennaway N.G., Soriano P. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev. 1993, 7:2298-2307.
28. Gutti T.L., Knibbe J.S., Makarov E., Zhang J., Yannam G.R., Gorantla S., Sun Y., Mercer D.F., Suemizu H., Wisecarver J.L., Osna N.A., Bronich T.K., Poluektova L.Y. Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice. Am. J. Pathol. 2014, 184:101-109.
29. Hasegawa M., Kawai K., Mitsui T., Taniguchi K., Monnai M., Wakui M., Ito M., Suematsu M., Peltz G., Nakamura M., Suemizu H. The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem. Biophys. Res. Commun. 2011, 405:405-410.
30. Heckel J.L., Sandgren E.P., Degen J.L., Palmiter R.D., Brinster R.L. Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 1990, 62:447-456.
31. Heo J., Factor V.M., Uren T., Takahama Y., Lee J.S., Major M., Feinstone S.M., Thorgeirsson S.S. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 2006, 44:1478-1486.
32. Horwitz J.A., Dorner M., Friling T., Donovan B.M., Vogt A., Loureiro J., Oh T., Rice C.M., Ploss A. Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein. Virology 2013, 439:23-33.
33. Ikeda M., Abe K., Dansako H., Nakamura T., Naka K., Kato N. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem. Biophys. Res. Commun. 2005, 329:1350-1359.
34. Ilan E., Arazi J., Nussbaum O., Zauberman A., Eren R., Lubin I., Neville L., Ben-Moshe O., Kischitzky A., Litchi A., Margalit I., Gopher J., Mounir S., Cai W., Daudi N., Eid A., Jurim O., Czerniak A., Galun E., Dagan S. The hepatitis C virus (HCV)-trimera mouse: a model for evaluation of agents against HCV. J. Infect. Dis. 2002, 185:153-161.
35. Jones D.M., Gretton S.N., McLauchlan J., Targett-Adams P. Mobility analysis of an NS5A--GFP fusion protein in cells actively replicating hepatitis C virus subgenomic RNA. J. Gen. Virol. 2007, 88:470-475.
36. Jones C.T., Catanese M.T., Law L.M., Khetani S.R., Syder A.J., Ploss A., Oh T.S., Schoggins J.W., MacDonald M.R., Bhatia S.N., Rice C.M. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat. Biotechnol. 2010, 28:167-171.
37. Kandathil A.J., Graw F., Quinn J., Hwang H.S., Torbenson M., Perelson A.S., Ray S.C., Thomas D.L., Ribeiro R.M., Balagopal A. Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver. Gastroenterology 2013, 145(1404-13):e1-e10.
38. Kapoor A., Simmonds P., Gerold G., Qaisar N., Jain K., Henriquez J.A., Firth C., Hirschberg D.L., Rice C.M., Shields S., Lipkin W.I. Characterization of a canine homolog of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11608-11613.
39. Karayiannis P., Petrovic L.M., Fry M., Moore D., Enticott M., McGarvey M.J., Scheuer P.J., Thomas H.C. Studies of GB hepatitis agent in tamarins. Hepatology 1989, 9:186-192.
40. Kawahara T., Toso C., Douglas D.N., Nourbakhsh M., Lewis J.T., Tyrrell D.L., Lund G.A., Churchill T.A., Kneteman N.M. Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transpl. 2010, 16:974-982.
41. -I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6:981-988.
42. Keller B.C., Johnson C.L., Erickson A.K., Gale M. Innate immune evasion by hepatitis C virus and West Nile virus. Cytokine Growth Factor Rev. 2007, 18:535-544.
43. Kosaka K., Hiraga N., Imamura M., Yoshimi S., Murakami E., Nakahara T., Honda Y., Ono A., Kawaoka T., Tsuge M., Abe H., Hayes C.N., Miki D., Aikata H., Ochi H., Ishida Y., Tateno C., Yoshizato K., Sasaki T., Chayama K. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Biochem. Biophys. Res. Commun. 2013, 441:230-235.
44. Koutsoudakis G., Kaul A., Steinmann E., Kallis S., Lohmann V., Pietschmann T., Bartenschlager R. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 2006, 80:5308-5320.
45. Kremsdorf D., Brezillon N. New animal models for hepatitis C viral infection and pathogenesis studies. World J. Gastroenterol. 2007, 13:2427-2435.
46. Lanford R.E., Chavez D., Notvall L., Brasky K.M. Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. Virology 2003, 311:72-80.
47. Laskus T., Radkowski M., Piasek A., Nowicki M., Horban A., Cianciara J., Rakela J. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J. Infect. Dis. 2000, 181:442-448.
48. Lau J.Y., Krawczynski K., Negro F., Gonzalez-Peralta R.P. In situ detection of hepatitis C virus-a critical appraisal. J. Hepatol. 1996, 24:43-51.
49. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale M., Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:2992-2997.
50. Liang Y., Shilagard T., Xiao S.Y., Snyder N., Lau D., Cicalese L., Weiss H., Vargas G., Lemon S.M. Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 2009, 137:1448-1458.
51. Lindenbach B.D., Rice C.M. The ins and outs of hepatitis C virus entry and assembly. Nat. Rev. Microbiol. 2013, 11:688-700.
52. Liu S., Yang W., Shen L., Turner J.R., Coyne C.B., Wang T. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 2009, 83:2011-2014.
53. Long G., Hiet M.S., Windisch M.P., Lee J.Y., Lohmann V., Bartenschlager R. Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Gastroenterology 2011, 141:1057-1066.
54. Lupberger J., Zeisel M.B., Xiao F., Thumann C., Fofana I., Zona L., Davis C., Mee C.J., Turek M., Gorke S., Royer C., Fischer B., Zahid M.N., Lavillette D., Fresquet J., Cosset F.L., Rothenberg S.M., Pietschmann T., Patel A.H., Pessaux P., Doffoel M., Raffelsberger W., Poch O., McKeating J.A., Brino L., Baumert T.F. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 2011, 17:589-595.
55. Lyubimova A., Itzkovitz S., Junker J.P., Fan Z.P., Wu X., van Oudenaarden A. Single-molecule mRNA detection and counting in mammalian tissue. Nat. Protoc. 2013, 8:1743-1758.
56. Martin D.N., Uprichard S.L. Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:10777-10782.
57. Marukian S., Andrus L., Sheahan T.P., Jones C.T., Charles E.D., Ploss A., Rice C.M., Dustin L.B. Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 2011, 54:1913-1923.
58. McCormick C.J., Maucourant S., Griffin S., Rowlands D.J., Harris M. Tagging of NS5A expressed from a functional hepatitis C virus replicon. J. Gen. Virol. 2006, 87:635-640.
59. Mercer D.F., Schiller D.E., Elliott J.F., Douglas D.N., Hao C., Rinfret A., Addison W.R., Fischer K.P., Churchill T.A., Lakey J.R., Tyrrell D.L., Kneteman N.M. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 2001, 7:927-933.
60. Meuleman P., Libbrecht L., De Vos R., de Hemptinne B., Gevaert K., Vandekerckhove J., Roskams T., Leroux-Roels G. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 2005, 41:847-856.
61. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
62. Molina S., Castet V., Fournier-Wirth C., Pichard-Garcia L., Avner R., Harats D., Roitelman J., Barbaras R., Graber P., Ghersa P., Smolarsky M., Funaro A., Malavasi F., Larrey D., Coste J., Fabre J.M., Sa-Cunha A., Maurel P. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J. Hepatol. 2007, 46:411-419.
63. Monazahian M., Bohme I., Bonk S., Koch A., Scholz C., Grethe S., Thomssen R. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 1999, 57:223-229.
64. Moradpour D., Evans M.J., Gosert R., Yuan Z., Blum H.E., Goff S.P., Lindenbach B.D., Rice C.M. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J. Virol. 2004, 78:7400-7409.
65. Moradpour D., Penin F., Rice C.M. Replication of hepatitis C virus. Nat. Rev. Microbiol. 2007, 5:453-463.
66. Morikawa K., Lange C.M., Gouttenoire J., Meylan E., Brass V., Penin F., Moradpour D. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J. Viral Hepat. 2011, 18:305-315.
67. Murray C.L., Rice C.M. Turning hepatitis C into a real virus. Annu. Rev. Microbiol. 2011, 65:307-327.
68. Nandakumar R., Finsterbusch K., Lipps C., Neumann B., Grashoff M., Nair S., Hochnadel I., Lienenklaus S., Wappler I., Steinmann E., Hauser H., Pietschmann T., Kroger A. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. Gastroenterology 2013, 145:1414-1423 e1.
69. Navas S., Martin J., Quiroga J.A., Castillo I., Carreno V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J. Virol. 1998, 72:1640-1646.
70. Owen D.M., Huang H., Ye J., Gale M. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology 2009, 394:99-108.
71. Palakkan A.A., Hay D.C., Anil Kumar P.R., Kumary T.V., Ross J.A. Liver tissue engineering and cell sources: issues and challenges. Liver Int. 2013, 33:666-676.
72. Pan K.L., Lee J.C., Sung H.W., Chang T.Y., Hsu J.T. Development of NS3/4A protease-based reporter assay suitable for efficiently assessing hepatitis C virus infection. Antimicrob. Agents Chemother. 2009, 53:4825-4834.
73. Pham T.N., King D., Macparland S.A., McGrath J.S., Reddy S.B., Bursey F.R., Michalak T.I. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008, 134:812-822.
74. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., Abrignani S. Binding of hepatitis C virus to CD81. Science 1998, 282:938-941.
75. Ploss A., Rice C.M. Towards a small animal model for hepatitis C. EMBO Rep. 2009.
76. Ploss A., Evans M.J., Gaysinskaya V.A., Panis M., You H., de Jong Y.P., Rice C.M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009, 457:882-886.
77. Ploss A., Khetani S.R., Jones C.T., Syder A.J., Trehan K., Gaysinskaya V.A., Mu K., Ritola K., Rice C.M., Bhatia S.N. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3141-3145.
78. Podevin P., Carpentier A., Pene V., Aoudjehane L., Carriere M., Zaidi S., Hernandez C., Calle V., Meritet J.F., Scatton O., Dreux M., Cosset F.L., Wakita T., Bartenschlager R., Demignot S., Conti F., Rosenberg A.R., Calmus Y. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 2010, 139:1355-1364.
79. Reed K.E., Xu J., Rice C.M. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J. Virol. 1997, 71:7187-7197.
80. Roelandt P., Obeid S., Paeshuyse J., Vanhove J., Van Lommel A., Nahmias Y., Nevens F., Neyts J., Verfaillie C.M. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J. Hepatol. 2012, 57:246-251.
81. Safran M., Kim W.Y., Kung A.L., Horner J.W., DePinho R.A., Kaelin W.G. Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination. Mol. Imaging 2003, 2:297-302.
82. Sainz B., Barretto N., Martin D.N., Hiraga N., Imamura M., Hussain S., Marsh K.A., Yu X., Chayama K., Alrefai W.A., Uprichard S.L. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat. Med. 2012, 18:281-285.
83. Sandmann L., Ploss A. Barriers of hepatitis C virus interspecies transmission. Virology 2013, 435:70-80.
84. Scarselli E., Ansuini H., Cerino R., Roccasecca R.M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002, 21:5017-5025.
85. Schaluder G.G., Dawson G.J., Simons J.N., Pilot-Matias T.J., Gutierrez R.A., Heynen C.A., Knigge M.F., Kurpiewski G.S., Buijk S.L., Leary T.P., et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J. Med. Virol. 1995, 46:81-90.
86. Schinazi R., Halfon P., Marcellin P., Asselah T. HCV direct-acting antiviral agents: the best interferon-free combinations. Liver Int. 2014, 34(Suppl. 1):69-78.
87. Schvarcz R., Weiland O., Wejstal R., Norkrans G., Fryden A., Foberg U. A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies. Scand. J. Infect. Dis. 1989, 21:617-625.
88. Schwartz R.E., Trehan K., Andrus L., Sheahan T.P., Ploss A., Duncan S.A., Rice C.M., Bhatia S.N. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2544-2548.
89. Seifert F., Struffert T., Hildebrandt M., Blumcke I., Bruck W., Staykov D., Huttner H.B., Hilz M.J., Schwab S., Bardutzky J. In vivo detection of hepatitis C virus (HCV) RNA in the brain in a case of encephalitis: evidence for HCV neuroinvasion. Eur. J. Neurol. 2008, 15:214-218.
90. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
91. Sheahan T., Jones C.T., Ploss A. Advances and challenges in studying hepatitis C virus in its native environment. Expert Rev. Gastroenterol. Hepatol. 2010, 4:541-550.
92. Sheahan T., Imanaka N., Marukian S., Dorner M., Liu P., Ploss A., Rice C.M. Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness. Cell Host Microbe 2014, 15:190-202.
93. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999, 21:70-71.
94. Srinivas S., Watanabe T., Lin C.S., William C.M., Tanabe Y., Jessell T.M., Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 2001, 1:4.
95. Stiffler J.D., Nguyen M., Sohn J.A., Liu C., Kaplan D., Seeger C. Focal distribution of hepatitis C virus RNA in infected livers. PLoS One 2009, 4:e6661.
96. Stoller J.Z., Degenhardt K.R., Huang L., Zhou D.D., Lu M.M., Epstein J.A. Cre reporter mouse expressing a nuclear localized fusion of GFP and beta-galactosidase reveals new derivatives of Pax3-expressing precursors. Genesis 2008, 46:200-204.
97. -/- Nod/Scid mice livers by human hepatocytes. Sci. China Life Sci. 2011, 54:227-234.
98. Suemizu H., Hasegawa M., Kawai K., Taniguchi K., Monnai M., Wakui M., Suematsu M., Ito M., Peltz G., Nakamura M. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice. Biochem. Biophys. Res. Commun. 2008, 377:248-252.
99. Sulkowski M.S., Gardiner D.F., Rodriguez-Torres M., Reddy K.R., Hassanein T., Jacobson I., Lawitz E., Lok A.S., Hinestrosa F., Thuluvath P.J., Schwartz H., Nelson D.R., Everson G.T., Eley T., Wind-Rotolo M., Huang S.P., Gao M., Hernandez D., McPhee F., Sherman D., Hindes R., Symonds W., Pasquinelli C., Grasela D.M. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N. Engl. J. Med. 2014, 370:211-221. AI444040 Study Group.
100. Tanaka Y., Mori Y., Tani H., Abe T., Moriishi K., Kojima H., Nagano T., Okabe T., Suzuki T., Tatsumi M., Matsuura Y. Establishment of an indicator cell system for hepatitis C virus. Microbiol. Immunol. 2013, 54:206-220.
101. Taylor D.R. Evolution of cell culture systems for HCV. Antivir. Ther. 2013, 18:523-530.
102. Tellinghuisen T.L., Evans M.J., von Hahn T., You S., Rice C.M. Studying hepatitis C virus: making the best of a bad virus. J. Virol. 2007, 81:8853-8867.
103. Tesfaye A., Stift J., Maric D., Cui Q., Dienes H.P., Feinstone S.M. Chimeric mouse model for the infection of hepatitis B and C viruses. PLoS One 2013, 8:e77298.
104. Tong X., Yin L. Circadian rhythms in liver physiology and liver diseases. Compr. Physiol. 2013, 3:917-940.
105. Torre C., Perret C., Colnot S. Molecular determinants of liver zonation. Prog. Mol. Biol. Transl. Sci. 2010, 97:127-150.
106. Uprichard S.L., Chung J., Chisari F.V., Wakita T. Replication of a hepatitis C virus replicon clone in mouse cells. Virol. J. 2006, 3:89.
107. Vanwolleghem T., Libbrecht L., Hansen B.E., Desombere I., Roskams T., Meuleman P., Leroux-Roels G. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice. J. Hepatol. 2010, 53:468-476.
108. Vogt A., Scull M.A., Friling T., Horwitz J.A., Donovan B.M., Dorner M., Gerold G., Labitt R.N., Rice C.M., Ploss A. Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. Virology 2013, 444:1-11.
109. Vrolijk J.M., Kaul A., Hansen B.E., Lohmann V., Haagmans B.L., Schalm S.W., Bartenschlager R. A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. J. Virol. Methods 2003, 110:201-209.
110. Washburn M.L., Bility M.T., Zhang L., Kovalev G.I., Buntzman A., Frelinger J.A., Barry W., Ploss A., Rice C.M., Su L. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011, 140:1334-1344.
111. Wieland S., Makowska Z., Campana B., Calabrese D., Dill M.T., Chung J., Chisari F.V., Heim M.H. Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver. Hepatology 2013, (Electronic publication ahead of print).
112. Wilkinson J., Radkowski M., Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. J. Virol. 2009, 83:1312-1319.
113. Wu X., Robotham J.M., Lee E., Dalton S., Kneteman N.M., Gilbert D.M., Tang H. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PloS Pathog. 2012, 8:e1002617.
114. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 2005, 19:727-740.
115. Xu X., Chen H., Cao X., Ben K. Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma. J. Gen. Virol. 2007, 88:2504-2512.
116. Zenklusen D., Singer R.H. Analyzing mRNA expression using single mRNA resolution fluorescent in situ hybridization. Methods Enzymol. 2010, 470:641-659.
117. Zeuzem S., Soriano V., Asselah T., Bronowicki J.P., Lohse A.W., Mullhaupt B., Schuchmann M., Bourliere M., Buti M., Roberts S.K., Gane E.J., Stern J.O., Vinisko R., Kukolj G., Gallivan J.P., Bocher W.O., Mensa F.J. Faldaprevir and deleobuvir for HCV genotype 1 infection. N. Engl. J. Med. 2013, 369:630-639.
118. Zhu Q., Guo J.T., Seeger C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J. Virol. 2003, 77:9204-9210.